News & Events

Congratulations to Maddie’s Vision Fellowship recipient Dr Vashe Chandrakanthan

We’re thrilled to announce that Developmental Stem cell Biologist Dr Vashe Chandrakanthan, from the South Australian Health and Medical Research Institute, The University of Adelaide, is the recipient of the Grant Round 2, 2022 Maddie’s Vision Fellowship for his project: “Discovery of novel niche factors to improve long-term stem cell transplantation in bone marrow failure syndromes”.

For many patients with Bone Marrow Failure Syndromes, bone marrow transplant is the only hope for a cure. However, for a transplant to be effective, the transplanted stem cells need to mature and develop into long-term healthy blood producing cells.  If this doesn’t happen, the transplant could fail. 

Currently, there are two major problems with the management of Bone Marrow Failure Syndrome patients that receive a bone marrow transplant: 

  • A growth factor treatment to stimulate stem cell recovery is limited to only one agent, thrombopoietin (eltrombopag), and the majority of patients treated with this fail to achieve adequate blood cell recovery. 
  • Patients with bone marrow failure syndromes such as Fanconi Syndrome experience difficulties with a bone marrow transplant because of changes in the surrounding tissue (the niche). 

Due to these issues, there is an urgent need to increase the number of marrow-stimulating molecules and improve stem cell outcomes for patients with severe marrow failure.

To address this, Dr Vashe Chandrakanthan and his team have devised a critical model of bone marrow failure. This has enabled them to discover a number of previously unrecognised growth factors and small molecules that regulate the most primitive blood stem cells that give rise to long-term healthy adult stem cells. 

Building on this discovery, Dr Chandrakanthan’s research focuses on developing a growth factor based treatment to help the transplanted stem cells to mature and produce healthy adult blood.

Dr Chandrakanthan’s research has potential to transform the transplantation management of patients with Aplastic Anaemia and Fanconi Syndrome and improve on current therapy.

Related Articles

Join our team – Project Coordinator, Centre of Research Excellence in Bone Marrow Biology

Join the Maddie Riewoldt’s Vision team and make a difference to the lives of people living with Bone Marrow Failure Syndromes and their families. As the Project Co-ordinator for ...

Read more

Oscar – a very special dog

Fiona Riewoldt speaks about how Oscar was with Maddie all the way through her fight and remains an important part of their family.

Read more

Collaboration and innovation shine at the Maddie Riewoldt’s Vision National Symposium on Bone Marrow Failure Syndromes

On October 13-15, the Maddie Riewoldt’s Vision Centre of Research Excellence in Bone Marrow Biology was proud to host the 3rd National Symposium on Bone Marrow Failure Syndromes. It was ...

Read more

Sign up to be the first to hear about our upcoming News & Events